Klaas Financial Asset Advisors, LLC
Filing Date
Global Rank
#6,634
/ 6,687
▲ 38
Top Industry
Drug Manufacturers - General
20.0%
3Y Alpha vs SPY
-10.4%
Period ended 3 years ago
Filed Oct 19, 2022 · 3y
8 quarters · since Dec 2020
Clone Performance
Jun 2023–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+32.9%
SPY
+74.2%
Annualised alpha
-10.4%
Max drawdown
−15.4%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
24 positions · as of Sep 30, 2022 · Δ vs Jun 30, 2022Top Position
12.4%
−2.4 pts
Top 5
43.3%
−9.9 pts
Top 10
72.1%
−11.9 pts
HHI
652
Diversified−179
Portfolio Trend
8 quarters · across all stocks
Sector Breakdown
As of Sep 30, 2022| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 33.8% | $180,234 |
| Utilities | 25.6% | $136,379 |
| Energy | 12.5% | $66,740 |
| Industrials | 11.5% | $61,001 |
| Consumer Cyclical | 9.0% | $47,731 |
| Consumer Defensive | 5.2% | $27,482 |
| Financial Services | 1.3% | $6,954 |
| Communication Services | 1.0% | $5,154 |
| Basic Materials | 0.2% | $915 |
Last Quarter's Activity
Export CSVTrimmed
Positions the filer reducedNo qualifying positions this quarter.
New Positions
Positions the filer opened this quarter
7 positions
5 positions ·
$180,234 total
· Healthcare only
· as of Sep 30, 2022
All sectors
Basic Materials
Communication Services
Consumer Cyclical
Consumer Defensive
Energy
Financial Services
Healthcare
Industrials
Utilities
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| UNH |
Unitedhealth Group Inc
Healthcare
|
Held | 131 | $66,160 | 36.71% | |
| MRK |
Merck & Co., Inc.
Healthcare
|
Held | 521 | $44,868 | 24.89% | |
| JNJ |
Johnson & Johnson
Healthcare
|
Held | 213 | $34,795 | 19.31% | |
| BIIB |
Biogen Inc.
Healthcare
|
Held | 100 | $26,700 | 14.81% | |
| ZTS |
Zoetis Inc.
Healthcare
|
Held | 52 | $7,711 | 4.28% |